Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

Brian Peters, Senior Vice President, ai² Division, Lōkahi Therapeutics

“This project reflects both the strength of our relationship with the University of Georgia and the natural next step in the evolution of our university network.”

Brian Peters, Senior Vice President, ai² Division, Lōkahi Therapeutics

“This expansion broadens both the talent and opportunity base available to Lōkahi while increasing our capacity to support external partners through sponsored projects and other strategic engagements.”

Brian Peters, Senior Vice President, ai² Division, Lōkahi Therapeutics

“Building on the model established with Innovate GBM, each addition to our university network strengthens the platform's potential to scale and generate revenue while continuing to expand the range of opportunities available to students and partners alike.”

Rüdiger Kabst, Professor and Entrepreneurship Chair at Universität Paderborn and Scientific Director for garage33

“garage33 empowers students to shape innovation, entrepreneurship and the future.”

Rüdiger Kabst, Professor and Entrepreneurship Chair at Universität Paderborn and Scientific Director for garage33

“This isn't simply an incredible opportunity to engage our students with Lōkahi Therapeutics™, this is a strategic connecting point for our German student innovators to expand our joint relationship with the Student Industry Fellows Program at UGA.”

Andrew H. Potter, Director of the Office of University Experiential Learning and founder and leader of the Student Industry Fellows Program at the University of Georgia

“This collaboration represents an exciting extension of what the Student Industry Fellows Program is designed to accomplish.”

Andrew H. Potter, Director of the Office of University Experiential Learning and founder and leader of the Student Industry Fellows Program at the University of Georgia

“Our relationship with Lōkahi has given students the opportunity to engage directly with complex, real-world questions at the intersection of business strategy, life sciences, and innovation.”